Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1971 2
1981 1
1982 3
1983 1
1984 2
1985 2
1986 2
1987 3
1988 1
1989 1
1990 2
1991 1
1992 3
1993 2
1994 2
1995 1
1996 5
1997 3
1998 7
1999 4
2000 4
2001 5
2002 2
2003 8
2004 4
2005 10
2006 8
2007 16
2008 15
2009 14
2010 14
2011 17
2012 17
2013 15
2014 22
2015 17
2016 18
2017 24
2018 16
2019 16
2020 21
2021 25
2022 18
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, Lodi G, Mello FW, Monteiro L, Ogden GR, Sloan P, Johnson NW. Warnakulasuriya S, et al. Oral Dis. 2021 Nov;27(8):1862-1880. doi: 10.1111/odi.13704. Epub 2020 Nov 26. Oral Dis. 2021. PMID: 33128420 Free article. Review.
The first workshop held in London in 2005 considered a wide spectrum of disorders under the term "potentially malignant disorders of the oral mucosa" (PMD) (now referred to as oral potentially malignant disorders: OPMD) including leukoplakia, erythroplakia, proliferative verrucou …
The first workshop held in London in 2005 considered a wide spectrum of disorders under the term "potentially malignant disorders of the ora …
Dyskeratosis congenita: a literature review.
AlSabbagh MM. AlSabbagh MM. J Dtsch Dermatol Ges. 2020 Sep;18(9):943-967. doi: 10.1111/ddg.14268. Epub 2020 Sep 15. J Dtsch Dermatol Ges. 2020. PMID: 32930426 Review.
Dyskeratosis congenita is a rare hereditary disease that occurs predominantly in males and manifests clinically as the classic triad of reticulate hyperpigmentation, nail dystrophy and leukoplakia. It increases the risk of malignancy and other potentially lethal com …
Dyskeratosis congenita is a rare hereditary disease that occurs predominantly in males and manifests clinically as the classic …
Telomeres-structure, function, and regulation.
Lu W, Zhang Y, Liu D, Songyang Z, Wan M. Lu W, et al. Exp Cell Res. 2013 Jan 15;319(2):133-41. doi: 10.1016/j.yexcr.2012.09.005. Epub 2012 Sep 21. Exp Cell Res. 2013. PMID: 23006819 Free PMC article. Review.
Aberrant regulation of telomeric proteins and/or telomerase may lead to abnormalities that can result in diseases such as dyskeratosis congenita (DC) and cancers. Understanding the mechanisms that regulate telomere homeostasis and the factors that contribute to telo …
Aberrant regulation of telomeric proteins and/or telomerase may lead to abnormalities that can result in diseases such as dyskeratosis …
Inherited bone marrow failure in the pediatric patient.
Dokal I, Tummala H, Vulliamy T. Dokal I, et al. Blood. 2022 Aug 11;140(6):556-570. doi: 10.1182/blood.2020006481. Blood. 2022. PMID: 35605178 Free PMC article.
They have also provided important information on fundamental biological pathways, including DNA repair: Fanconi anemia (FA) genes; telomere maintenance: dyskeratosis congenita (DC) genes; and ribosome biogenesis: Shwachman-Diamond syndrome and Diamond-Blackfan anemi …
They have also provided important information on fundamental biological pathways, including DNA repair: Fanconi anemia (FA) genes; telomere …
Dyskeratosis Congenita.
Stoopler ET, Shanti RM. Stoopler ET, et al. Mayo Clin Proc. 2019 Sep;94(9):1668-1669. doi: 10.1016/j.mayocp.2019.04.032. Mayo Clin Proc. 2019. PMID: 31486376 Review. No abstract available.
Dyskeratosis congenita.
Keeling B, Antia C, Steadmon M, Wesson S, Williams C. Keeling B, et al. Dermatol Online J. 2014 Sep 16;20(9):13030/qt2k99x2kq. Dermatol Online J. 2014. PMID: 25244172
IMPORTANCE: Dyskeratosis congenita is a rare disorder that often leads to early death owing to a variety of complications and associated disorders. Early diagnosis and intervention is important in care for patients affected by this disease. OBSERVATIONS: We describe …
IMPORTANCE: Dyskeratosis congenita is a rare disorder that often leads to early death owing to a variety of complications and …
Dyskeratosis congenita.
Savage SA, Alter BP. Savage SA, et al. Hematol Oncol Clin North Am. 2009 Apr;23(2):215-31. doi: 10.1016/j.hoc.2009.01.003. Hematol Oncol Clin North Am. 2009. PMID: 19327580 Free PMC article.
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized clinically by the triad of abnormal nails, reticular skin pigmentation, and oral leukoplakia, and is associated with high risk of developing aplastic anemia, myelodysplastic syndr …
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized clinically by the triad of abnormal nai …
Dyskeratosis Congenita.
Kelmenson DA, Hanley M. Kelmenson DA, et al. N Engl J Med. 2017 Apr 13;376(15):1460. doi: 10.1056/NEJMicm1613081. N Engl J Med. 2017. PMID: 28402761 Free article. No abstract available.
346 results